TORCH Panel (IgG and IgM)

About the Test

The TORCH IgG & IgM Evaluation test is a comprehensive serological panel designed to detect maternal exposure to a group of infections that are known to significantly impact fetal development. The acronym TORCH represents Toxoplasma gondii, Rubella virus, Cytomegalovirus (CMV), and Herpes simplex virus (HSV). These pathogens are particularly important in obstetric care because they can cross the placental barrier and cause congenital infections, leading to severe fetal complications.

The TORCH IgG & IgM Evaluation test measures two classes of antibodies:

• IgM antibodies – indicative of recent or acute infection
• IgG antibodies – indicative of past exposure or immunity

Understanding the distinction between these antibodies is critical. IgM antibodies typically appear early during infection and suggest recent exposure, whereas IgG antibodies persist long-term and often indicate prior infection or vaccination-induced immunity.

The TORCH IgG & IgM Evaluation test plays a crucial role in prenatal screening, particularly in high-risk pregnancies or when fetal anomalies are suspected on ultrasound. It helps clinicians assess the risk of vertical transmission and guides further diagnostic and management strategies.

Why Consider This Test?

The TORCH IgG & IgM Evaluation test is essential because infections caused by TORCH agents can lead to a wide range of adverse pregnancy outcomes. These infections are often asymptomatic or mildly symptomatic in the mother but can have devastating consequences for the fetus.

Potential Fetal Complications Include

• Congenital malformations
• Intrauterine growth restriction (IUGR)
• Microcephaly or hydrocephalus
• Sensorineural hearing loss
• Vision impairment
• Developmental delay
• Stillbirth or neonatal death

Each component of the TORCH panel carries specific risks:

• Toxoplasma: Associated with neurological and ocular damage
• Rubella: Can cause congenital rubella syndrome (CRS) with cardiac defects and deafness
• CMV: Leading cause of congenital viral infection, associated with hearing loss and neurodevelopmental delay
• HSV: Can cause severe neonatal infections affecting skin, eyes, and central nervous system

Clinical Utility

The TORCH IgG & IgM Evaluation test is particularly valuable in:

• Identifying recent infections during pregnancy
• Assessing immune status prior to conception
• Investigating recurrent pregnancy loss
• Evaluating fetal anomalies detected on ultrasound

Who Should Get This Test Done?

Primary Indications

• Pregnant women, especially in early pregnancy
• Women planning pregnancy
• Patients with history of recurrent miscarriages

Clinical Indications

• Suspected intrauterine infection
• Ultrasound findings suggestive of fetal anomalies
• Neonates with signs of congenital infection

High-Risk Groups

• Women with exposure to:
• Raw or undercooked meat (toxoplasmosis risk)
• Infected individuals (rubella, CMV)
• Healthcare workers or caregivers

More Information

Interpretation of Results

• IgM Positive / IgG Negative → Recent infection
• IgM Positive / IgG Positive → Possible recent infection (requires confirmation)
• IgM Negative / IgG Positive → Past infection or immunity
• IgM Negative / IgG Negative → No exposure; susceptible individual

Important Considerations

• False positives may occur, especially with IgM
• Confirmatory tests (e.g., avidity testing, PCR) may be required
• Timing of infection is critical for fetal risk assessment

Clinical Relevance

Early detection through the TORCH IgG & IgM Evaluation test allows for:

• Timely intervention
• Risk stratification
• Counseling regarding pregnancy outcomes